Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19

Abstract Background Both BNT162b2 (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccines have shown high efficacy against COVID-19 in randomized controlled trials. However, their comparative effectiveness against COVID-19 is unclear in the real world. We evaluated the comparative effect...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jie Wei, Weiya Zhang, Michael Doherty, Zachary S. Wallace, Jeffrey A. Sparks, Na Lu, Xiaoxiao Li, Chao Zeng, Guanghua Lei, Yuqing Zhang
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2023-02-01
Цуврал:	BMC Medicine
Нөхцлүүд:	COVID-19 Vaccine BNT162b2 ChAdOx1 nCoV-19
Онлайн хандалт:	https://doi.org/10.1186/s12916-023-02795-w
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!